AMAda Mendoza

Ada Mendoza

*This is an algorithmically generated author record based on publicly available information.

Ada Mendoza has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cytochemical analysis of cerebrospinal fluid in tuberculous meningitis versus other etiologies

    by Miguel Hueda-Zavaleta, Juan C. Gómez de la Torre, Claudia Barletta-Carrillo, Gustavo Tapia-Sequeiros, Cinthya Flores, Cristian Piscoche, Cecilia Miranda, Ada Mendoza, Marco Sánchez-Tito, Vicente A. Benites-Zapata

    Background: Meningeal tuberculosis (TBM) is the most severe form of extrapulmonary tuberculosis due to its high mortality and long-term sequelae in survivors. Methods: A cross-sectional study of diagnostic tests was carried out in a private clinical laboratory in Lima, Peru. All cerebrospinal fluid (CSF) samples from patients with suspected meningitis were analyzed with cytochemical and biochemical studies, as well as smear microscopy, India ink, the FilmArray Meningitis/Encephalitis panel, Xpert® MTB/RIF or Xpert MTB/RIF Ultra, and culture for common bacterias, fungi or mycobacterial. Results: 450 CSF samples were included. The main microorganisms detected were Mycobacterium tuberculosis (8.9%), Cryptococcus neoformans (6.0%), and Streptococcus pneumoniae (2.4%). 97.5% of patients with TBM presented positive Xpert MTB/RIF or Ultra. The median number of red blood cells, leukocytes, and percentage of mononuclear cells, glucose, and proteins in the CSF was 57.5 cells/μl, 91.5 cells/μl, 70%, 22.5 mg/dL and 218.3 mg/dL, respectively. Likewise, patients with TMB had the lowest glucose levels (median: 22.5, IQR: 11 - 35) compared to other etiologies of meningitis. While bacterial meningitis had the highest leukocyte (median: 173 μl; IQR: 17 - 520) and protein levels (median: 289.7; IQR: 92 - 556). Conclusion: The characteristics of the cytochemical study of CSF can guide the differential diagnosis by identifying general trends of tuberculous meningitis and other meningitis etiologies. However, it remains necessary to establish methods with greater precision to properly define the etiological agent causing meningitis.


  • Open Access

    Diagnostic performance of Ziehl-Neelsen staining and Auramine-Rhodamine staining techniques in the detection of pulmonary and extrapulmonary tuberculosis

    by Gustavo Tapia-Sequeiros, Miguel Hueda-Zavaleta, Juan Carlos Gómez de la Torre, Arantsa Hernandez-Vargas, Claudia Barletta-Carrillo, Cinthya Flores, Cristian Piscoche, Cecilia Miranda, Ada Mendoza

    Objetivo. Determinar el rendimiento diagnóstico de la tinción Ziehl-Neelsen y Auramina-Rodamina para tuberculosis pulmonar y extrapulmonar. Materiales y métodos. Se realizó un estudio transversal de prueba diagnóstica. Se utilizó una base de datos de muestras procesadas de pacientes con sospecha de tuberculosis pulmonar y extrapulmonar en un laboratorio privado de Perú entre el 2011 y 2022. Las pruebas índices fueron la tinción Ziehl-Neelsen y tinción Auramina-Rodamina. Las pruebas de referencia fueron Xpert MTB/RIF y Xpert Ultra. Se calculó las características operativas del receptor y área bajo la curva (AUC/ROC) para determinar el rendimiento diagnóstico de cada técnica de baciloscopia. Resultados. Analizamos 908 muestras procesadas por tinción Ziehl-Neelsen y 623 muestras por tinción Auramina-Rodamina siendo la mayoría de origen pulmonar. Al tomar como referencia al Xpert MTB/RIF, la tinción Ziehl-Neelsen obtuvo un AUC=0,72 con una sensibilidad del 44,2% y especificidad del 99,3%; y la tinción Auramina-Rodamina un AUC=0,73 con una sensibilidad del 46,8% y especificidad del 100%. Al tomar como referencia el Xpert Ultra, el rendimiento diagnóstico para la tinción Ziehl-Neelsen fue AUC=0,63 con una sensibilidad del 26,9% y especificidad del 98,5%; y para la tinción Auramina-Rodamina fue AUC=0,64 con una sensibilidad del 30% y especificidad del 98,2%. Conclusión. El rendimiento diagnóstico para ambas técnicas de baciloscopia es regular, y disminuye al tomar como referencia al Xpert Ultra. Es necesario el uso de nuevas alternativas diagnosticas con un rendimiento adecuado para detectar tuberculosis.


  • Open Access

    Diagnostic accuracy of Xpert MTB/RIF and Xpert ultra tests in pulmonary and extrapulmonary tuberculosis compared to Löwenstein-Jensen culture

    by Miguel Hueda-Zavaleta, Juan Gomez-De-La-Torre, Claudia Barletta-Carrillo, Cinthya Flores-Flores, Nilver Piscoche-Botello, Cecilia Miranda-Visalot, Ada Mendoza-Farro, Sujey Gomez-Colque, Álvaro Taype-Rondán, Cesar Copaja-Corzo


  • Open Access

    Diagnostic performance of the Cobas MTB and Logix Smart MTB for diagnosing pulmonary and extrapulmonary tuberculosis: a cross-sectional study of diagnostic tests

    by Miguel Hueda-Zavaleta, Juan Carlos Gomez de la Torre, Diana Minchón-Vizconde, Claudia Barletta-Carrillo, Cesar Copaja-Corzo, Gustavo Tapia-Sequeiros, Cinthya Flores, Cristian Piscoche, Cecilia Miranda, Ada Mendoza, et al.

    Background: Molecular tests have contributed to reducing the mortality rate through early and accurate diagnosis of tuberculosis (TB). This is due to their low processing complexity and diagnostic accuracy superior to conventional methods. Objective: To evaluate the diagnostic performance of Cobas MTB and Logix Smart MTB compared to Xpert MTB/RIF Ultra for pulmonary tuberculosis (PTB) and extrapulmonary tuberculosis (EPTB). Design: A cross-sectional study of diagnostic tests was carried out in a clinical laboratory in Lima, Peru. Methods: All pulmonary and extrapulmonary samples from patients with presumptive TB who had been subjected to smear microscopy, Xpert MTB/RIF Ultra, Cobas MTB, Logix Smart MTB, and mycobacteria culture were included to determine their diagnostic performance. Results: A total of 175 samples were included, 102 (58.3%) of pulmonary origin and 73 (41.7%) of extrapulmonary origin. Among the total samples, 19 (10.9%) had positive cultures (all were pulmonary samples), 48 (27.4%) had positive Xpert MTB/RIF Ultra results, 45 (25.7%) had positive Cobas MTB results, and 36 (20.6%) had positive Logix Smart MTB results. The agreement between Cobas MTB and Logix Smart with the Xpert MTB/RIF Ultra was 97.1% and 93.8%, respectively. Compared to Xpert MTB/RIF Ultra, the area under the curve/receiver operating characteristic and sensitivity of the Cobas MTB and Logix Smart methods were 0.95 and 91.7%, and 0.90 and 81.0%, respectively. Conclusion: Cobas MTB and Logix Smart presented adequate performance for diagnosing pulmonary and extrapulmonary tuberculosis comparable to the Xpert MTB/RIF Ultra.